CoChat

Estrogens protect male mice from obesity complications and influence glucocorticoid metabolism

Open access
Dakin, R S, Walker, B R, Seckl, J R, Hadoke, P W F, Drake, A J · 2015 · International Journal of Obesity
Cited by 92

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Although the prevalence of obesity is higher among women than men, they are somewhat protected from the associated cardiometabolic consequences. The increase in cardiovascular disease risk seen after the menopause suggests a role for estrogens. There is also growing evidence for the importance of estrogen on body fat and metabolism in males. We hypothesized that that estrogen administration would ameliorate the adverse effects of obesity on metabolic parameters in males. METHODS: Male and female C57Bl/6 mice were fed control or obesogenic (DIO) diets from 5 weeks of age until adulthood. Glucose tolerance testing was performed at 13 weeks of age. Mice were killed at 15 weeks of age and liver and adipose tissue were collected for analysis of gene expression. A second cohort of male mice underwent the same experimental design with the addition of estradiol pellet implantation or sham surgery at 6 weeks. RESULTS: DIO males had greater mesenteric adipose deposition and more severe increases in plasma glucose, insulin and lipids than females. Treatment of males with estradiol from 6 weeks of age prevented DIO-induced increases in adipose tissue mass and alterations in glucose-insulin homeostasis. We also identified sex differences in the transcript levels and activity of hepatic and adipose glucocorticoid metabolizing enzymes. Estrogen treatment feminized the pattern of DIO-induced changes in glucocorticoid metabolism, rendering males similar to females. CONCLUSIONS: Thus, DIO induces sex-specific changes in glucose-insulin homeostasis, which are ameliorated in males treated with estrogen, highlighting the importance of sex steroids in metabolism. Given that altered peripheral glucocorticoid metabolism has been observed in rodent and human obesity, our results also suggest that sexually dimorphic expression and activity of glucocorticoid metabolizing enzymes may have a role in the differential metabolic responses to obesity in males and females.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ijo.2015.102

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 42

  1. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 2007; 85: 1197–1202. · DOI · Paper page
  2. Noonan WT, Banks RO . Renal function and glucose transport in male and female mice with diet-induced type II diabetes mellitus. Proc Soc Exp Biol Med 2000; 225: 221–223. · doi:10.1046/j.1525-1373.2000.22528.x
  3. Stubbins R, Holcomb V, Hong J, Núñez N . Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutrition 2012; 51: 861–870. · DOI · Paper page
  4. Maher MA, Banz WJ, Truett GE, Zemel MB . Dietary fat and sex modify heterozygote effects of the rat Fatty (fa) allele. J Nutr 1996; 126: 2487–2493. · DOI
  5. Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE . Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis 2000; 148: 231–241. · DOI · Paper page
  6. Donahue RP, Bean JA, Donahue RA, Goldverg RB, Prineas RJ . Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study. Diabetes Care 1997; 20: 1670–1676. · DOI · Paper page
  7. Fox CS, Yang Q, Cupples LA, Guo C-Y, Atwood LD, Murabito JM et al. Sex-specific association between estrogen receptor-α gene variation and measures of adiposity: The Framingham Heart Study. J Clin Endocrinol Metab 2005; 90: 6257–6262. · DOI
  8. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metabol 2004; 89: 61–70. · DOI · Paper page
  9. Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricquier D et al. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci USA 1998; 95: 4061–4065. · DOI · Paper page
  10. Holmes MC, French KL, Seckl JR . Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Brain Res Mol Res 1995; 28: 186–192. · DOI
  11. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000; 141: 560–563. · DOI · Paper page
  12. King V, Dakin RS, Liu L, Hadoke PW, Walker BR, Seckl JR et al. Maternal obesity has little effect on the immediate offspring but impacts on the next generation. Endocrinology 2013; 154: 2514–2524. · DOI · Paper page
  13. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418–1421. · doi:10.1210/jcem.86.3.7453 · Paper page
  14. Kotani K, Tiokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Dis 1994; 18: 207–212.
  15. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS . Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 2005; 280: 35983–35991. · DOI · Paper page
  16. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069–1075. · DOI · Paper page
  17. Zhu L, Martinez MN, Emfinger CH, Palmisano BT, Stafford JM . Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. Am J Physiol Endocrinol Metab 2014; 306: E1188–E1197. · DOI · Paper page
  18. Camporez JPG, Jornayvaz FR, Lee H-Y, Kanda S, Guigni BA, Kahn M et al. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology 2013; 154: 1021–1028. · DOI · Paper page
  19. Mauvais-Jarvis F, Clegg DJ, Hevener AL . The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 2013; 34: 309–338. · DOI · Paper page
  20. Wang X, Lu Y, Wang E, Zhang Z, Xiong X, Zhang H et al. Hepatic estrogen receptor α improves hepatosteatosis through up-regulation of small heterodimer partner. J Hepatol 2015. e-pub ahead of print 24 February 2015 doi:10.1016/j.jhep.2015.02.029. · DOI
  21. Auvinen HE, Romijn JA, Biermasz NR, Pijl H, Havekes LM, Smit JWA et al. The effects of high fat diet on the basal activity of the hypothalamus–pituitary–adrenal axis in mice. J Endocrinol 2012; 214: 191–197. · DOI · Paper page
  22. Drake AJ, Livingstone DEW, Andrew R, Seckl JR, Morton NM, Walker BR . Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology 2005; 146: 913–919. · DOI · Paper page
  23. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002; 87: 3330–3336.
  24. Paulsen SK, Pedersen SB, Fisker S, Richelsen B . 11beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity and fat localisation. Obesity 2007; 15: 1954–1960. · DOI · Paper page
  25. Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR . Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1. J Endocrinol 1999; 160: 103–109. · DOI · Paper page
  26. Gomez-Sanchez EP, Ganjam V, Chen YJ, Liu Y, Zhou MY, Toroslu C et al. Regulation of 11β-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. Am J Physiol 2003; 285: E272–E279.
  27. Tagawa N, Yuda R, Kubota S, Wakabayashi M, Yamaguchi Y, Kiyonaga D et al. 17β-Estradiol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes. J Endocrinol 2009; 202: 131–139. · DOI
  28. Andersson T, Simonyte K, Andrew R, Strand M, Burén J, Walker BR et al. Tissue-specific increases in 11β-Hydroxysteroid Dehydrogenase Type 1 in normal weight postmenopausal women. PLoS ONE 2009; 4: e8475. · DOI · Paper page
  29. Morton NM, Ramage LE, Seckl JR . Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: A potential adaptive mechanism counteracting metabolic disease. Endocrinology 2004; 145: 2707–2712. · DOI · Paper page
  30. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 1997; 94: 14924–14929. · DOI · Paper page
  31. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001; 276: 41293–41300. · DOI · Paper page
  32. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S et al. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 2003; 144: 4755–4762. · DOI · Paper page
  33. Berthiaume M, Laplante M, Festuccia W, Gélinas Y, Poulin S, Lalonde J et al. Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11β-hydroxysteroid dehydrogenase type 1. Endocrinology 2007; 148: 2391–2397. · DOI · Paper page
  34. Chapman KE, Kotelevtsev YV, Jamieson PM, Williams LJ, Mullins JJ, Seckl JR . Tissue-specific modulation of glucocorticoid action by the 11 beta-hydroxysteroid dehydrogenases. Biochem Soc Trans 1997; 25: 583–587. · DOI
  35. McInnes KJ, Kenyon CJ, Chapman KE, Livingstone DEW, Macdonald LJ, Walker BR et al. 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. J Biol Chem 2004; 279: 22908–22912. · DOI · Paper page
  36. Andrew R, Phillips DI, Walker BR . Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 1998; 83: 1806–1809. · doi:10.1210/jcem.83.5.4951 · Paper page
  37. Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB . Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity 2008; 16: 731–735. · DOI
  38. Wake DJ, Homer NZM, Andrew R, Walker BR . Acute in vivo regulation of 11β-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. J Clin Endocrinol Metab 2006; 91: 4682–4688. · DOI · Paper page
  39. Livingstone DE, McInnes KJ, Walker BR, Andrew R . Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. Obes Res 2005; 13: 1523–1526. · DOI
  40. Andersson B, Mattsson L-Å, Hahn L, MÅrin P, Lapidus L, Holm G et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 638–643.
  41. Spencer CP, Godsland IF, Cooper AJ, Ross D, Whitehead MI, Stevenson JC . Effects of oral and transdermal 17β-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. Metabolism 2000; 49: 742–747. · DOI
  42. Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 1998; 21: 1589–1595. · DOI · Paper page

Cited by

See all 92

Metadata

Authors
Dakin, R. S., Walker, B. R., Seckl, J. R., Hadoke, P. W. F., & Drake, A. J.
Venue
International Journal of Obesity
Published
2015-06-02
Volume
39
Issue
10
Pages
1539-1547
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
OpenAlex
W1635904172
Cited by
92
References
16
FWCI
4.93
Type
journal article
Language
en
Open access
hybrid
Licence
creativecommons.org/licenses/by/4.0 (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogens protect male mice from obesity complications and influence glucocorticoid metabolism. https://app.cochat.ai/papers/10.1038/ijo.2015.102
The paper
Dakin, R. S., Walker, B. R., Seckl, J. R., Hadoke, P. W. F., & Drake, A. J. (2015). Estrogens protect male mice from obesity complications and influence glucocorticoid metabolism. International Journal of Obesity. https://doi.org/10.1038/ijo.2015.102

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.